NETANYA, Israel--(BUSINESS WIRE)--NewVert Ltd., today announced appointment of Jeffrey Lotz, PhD, to the Clinical Advisory Board (CAB) for its Octopus Spinal Annular Repair System (OSA)2. The CAB will meet periodically to assess the development strategies for OSA and advise the company on the state of the spinal repair market. Ory Keynan, MD, Chairman of the CAB commented, “Dr. Lotz is a world leader in the application of bioengineering to orthopedic implants. Dr. Lotz will bring tremendous experience to the CAB as we continue the development of the Octopus Spinal Annular Repair System. The world-class clinical capabilities and real-life experiences represented by this CAB in orthopedic implants and spinal surgical repair make this group uniquely suited to support the ongoing development of NewVert’s Octopus technology.”
